Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 5 | 2021 | 148 | 1.250 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 463 | 0.990 |
Why?
|
| Sequence Analysis, RNA | 4 | 2021 | 233 | 0.840 |
Why?
|
| B-Lymphocytes | 3 | 2021 | 739 | 0.790 |
Why?
|
| Supervised Machine Learning | 1 | 2021 | 10 | 0.770 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 37 | 0.750 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2019 | 131 | 0.750 |
Why?
|
| Immunotherapy | 4 | 2022 | 682 | 0.730 |
Why?
|
| Immune System | 2 | 2017 | 97 | 0.630 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 167 | 0.620 |
Why?
|
| Immunity, Innate | 2 | 2019 | 430 | 0.610 |
Why?
|
| Genomics | 4 | 2021 | 762 | 0.590 |
Why?
|
| MicroRNAs | 5 | 2018 | 551 | 0.580 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2018 | 116 | 0.570 |
Why?
|
| Allergy and Immunology | 1 | 2017 | 13 | 0.570 |
Why?
|
| Gene Expression Profiling | 6 | 2019 | 1431 | 0.560 |
Why?
|
| Polymorphism, Genetic | 2 | 2019 | 825 | 0.550 |
Why?
|
| Biomarkers, Tumor | 4 | 2022 | 1549 | 0.520 |
Why?
|
| Gene Expression | 4 | 2021 | 1310 | 0.500 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 1976 | 0.460 |
Why?
|
| Software | 2 | 2018 | 665 | 0.450 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1120 | 0.430 |
Why?
|
| Computational Biology | 4 | 2021 | 543 | 0.410 |
Why?
|
| Neoplasms | 4 | 2021 | 3041 | 0.400 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 2362 | 0.340 |
Why?
|
| Mice | 16 | 2022 | 11761 | 0.310 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2021 | 165 | 0.290 |
Why?
|
| Transfection | 1 | 2009 | 911 | 0.290 |
Why?
|
| Precision Medicine | 3 | 2021 | 410 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 3218 | 0.290 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 557 | 0.290 |
Why?
|
| Dendritic Cells | 3 | 2017 | 449 | 0.290 |
Why?
|
| Animals | 18 | 2022 | 27371 | 0.260 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2018 | 135 | 0.250 |
Why?
|
| Transcriptome | 3 | 2021 | 630 | 0.250 |
Why?
|
| Interferon Regulatory Factors | 3 | 2017 | 69 | 0.240 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 465 | 0.240 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 481 | 0.240 |
Why?
|
| Immune Tolerance | 2 | 2017 | 339 | 0.230 |
Why?
|
| Interleukin-4 | 2 | 2021 | 130 | 0.220 |
Why?
|
| Population Health | 1 | 2023 | 33 | 0.220 |
Why?
|
| Linkage Disequilibrium | 1 | 2024 | 477 | 0.210 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 1157 | 0.210 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2021 | 44 | 0.210 |
Why?
|
| Retroviridae | 1 | 2022 | 79 | 0.200 |
Why?
|
| Humans | 21 | 2024 | 89357 | 0.200 |
Why?
|
| Receptors, Cytokine | 1 | 2021 | 28 | 0.190 |
Why?
|
| STAT6 Transcription Factor | 1 | 2021 | 28 | 0.190 |
Why?
|
| Databases, Nucleic Acid | 1 | 2021 | 41 | 0.190 |
Why?
|
| Organoids | 1 | 2021 | 62 | 0.190 |
Why?
|
| Models, Immunological | 1 | 2021 | 81 | 0.190 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2021 | 42 | 0.190 |
Why?
|
| Allografts | 1 | 2021 | 181 | 0.180 |
Why?
|
| Immunity, Humoral | 2 | 2018 | 66 | 0.180 |
Why?
|
| Leukemia | 1 | 2022 | 323 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2024 | 2340 | 0.180 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 308 | 0.180 |
Why?
|
| Defensins | 1 | 2019 | 5 | 0.170 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 362 | 0.170 |
Why?
|
| Cell Differentiation | 5 | 2018 | 1525 | 0.170 |
Why?
|
| Antigen Presentation | 3 | 2017 | 215 | 0.170 |
Why?
|
| Major Histocompatibility Complex | 1 | 2019 | 84 | 0.170 |
Why?
|
| Bacteria | 2 | 2022 | 478 | 0.170 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 160 | 0.160 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 445 | 0.160 |
Why?
|
| Signal Transduction | 2 | 2021 | 3385 | 0.160 |
Why?
|
| Models, Biological | 4 | 2021 | 1765 | 0.160 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 142 | 0.160 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 248 | 0.160 |
Why?
|
| Plasma Cells | 1 | 2018 | 84 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 595 | 0.150 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 82 | 0.150 |
Why?
|
| Germinal Center | 1 | 2018 | 55 | 0.150 |
Why?
|
| Rauscher Virus | 1 | 2017 | 8 | 0.150 |
Why?
|
| HLA-D Antigens | 1 | 2017 | 20 | 0.150 |
Why?
|
| Influenza Vaccines | 1 | 2018 | 149 | 0.150 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2017 | 64 | 0.140 |
Why?
|
| Retroviridae Infections | 1 | 2017 | 48 | 0.140 |
Why?
|
| Immunologic Techniques | 1 | 2017 | 26 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2017 | 306 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1088 | 0.140 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 120 | 0.140 |
Why?
|
| Th2 Cells | 2 | 2017 | 147 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2021 | 1097 | 0.140 |
Why?
|
| Vaccination | 1 | 2018 | 274 | 0.140 |
Why?
|
| Autoimmunity | 2 | 2018 | 168 | 0.140 |
Why?
|
| Intestines | 1 | 2019 | 416 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2401 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 866 | 0.130 |
Why?
|
| Inflammation | 1 | 2021 | 972 | 0.130 |
Why?
|
| Graft Rejection | 1 | 2021 | 1070 | 0.130 |
Why?
|
| RNA | 1 | 2019 | 580 | 0.120 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 805 | 0.120 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2014 | 13 | 0.120 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2014 | 8 | 0.120 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 1574 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 850 | 0.120 |
Why?
|
| fas Receptor | 1 | 2014 | 77 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 1265 | 0.110 |
Why?
|
| Immunity | 1 | 2014 | 141 | 0.110 |
Why?
|
| Proteins | 1 | 2018 | 787 | 0.110 |
Why?
|
| Androgens | 1 | 2013 | 176 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 509 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 1 | 2012 | 65 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2012 | 58 | 0.100 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2012 | 46 | 0.100 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 319 | 0.100 |
Why?
|
| Male | 9 | 2024 | 42411 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2012 | 85 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2013 | 184 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 294 | 0.100 |
Why?
|
| Female | 9 | 2024 | 46202 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 249 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2014 | 1653 | 0.090 |
Why?
|
| Lymphocyte Activation | 4 | 2014 | 751 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 160 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 54 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 2558 | 0.090 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2009 | 3 | 0.080 |
Why?
|
| Genes, cdc | 1 | 2009 | 5 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2012 | 265 | 0.080 |
Why?
|
| Cell Line | 2 | 2014 | 2496 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 306 | 0.080 |
Why?
|
| Autoantibodies | 2 | 2021 | 268 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 247 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 560 | 0.080 |
Why?
|
| Protein Binding | 3 | 2018 | 1488 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1242 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2009 | 727 | 0.070 |
Why?
|
| Antibodies, Viral | 2 | 2018 | 309 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 1671 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2017 | 2001 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 308 | 0.060 |
Why?
|
| Whole Genome Sequencing | 1 | 2024 | 87 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2009 | 945 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2024 | 685 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 34 | 0.050 |
Why?
|
| Palatine Tonsil | 1 | 2021 | 30 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2023 | 169 | 0.050 |
Why?
|
| Loss of Heterozygosity | 1 | 2021 | 86 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 78 | 0.050 |
Why?
|
| Fluorescence | 1 | 2021 | 103 | 0.050 |
Why?
|
| Symbiosis | 1 | 2022 | 127 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1652 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2022 | 211 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 887 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 371 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 201 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 695 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2021 | 227 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2024 | 1862 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2023 | 900 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 996 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2018 | 83 | 0.040 |
Why?
|
| CD40 Antigens | 1 | 2018 | 44 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 76 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2884 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 337 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2024 | 1374 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2018 | 275 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 286 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 262 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2017 | 76 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2017 | 511 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 166 | 0.030 |
Why?
|
| Kidney | 1 | 2021 | 1147 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2017 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2017 | 172 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1224 | 0.030 |
Why?
|
| Vero Cells | 1 | 2014 | 103 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 49 | 0.030 |
Why?
|
| Nippostrongylus | 1 | 2013 | 4 | 0.030 |
Why?
|
| Strongylida Infections | 1 | 2013 | 7 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2013 | 12 | 0.030 |
Why?
|
| Interleukin-33 | 1 | 2013 | 25 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 25974 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 2013 | 36 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 48 | 0.030 |
Why?
|
| Castration | 1 | 2013 | 41 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2013 | 38 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 466 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 126 | 0.030 |
Why?
|
| Transgenes | 1 | 2013 | 185 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2014 | 153 | 0.030 |
Why?
|
| Interleukins | 1 | 2013 | 129 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 195 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2014 | 342 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 803 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2013 | 105 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 309 | 0.030 |
Why?
|
| Metagenome | 1 | 2013 | 105 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 5499 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 136 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 237 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 691 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 983 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 58 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 191 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2013 | 451 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2013 | 471 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1117 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 128 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2013 | 326 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 306 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 950 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 323 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 590 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 571 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 794 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 1224 | 0.020 |
Why?
|
| Survival Rate | 1 | 2011 | 1901 | 0.020 |
Why?
|
| Lung | 1 | 2013 | 1263 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 767 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 4143 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1717 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 3160 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 3731 | 0.010 |
Why?
|
| Child | 1 | 2011 | 7174 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 6312 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 9263 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 26607 | 0.010 |
Why?
|